-
Oct. 31, 2024
IR
Annual Report 2024 and Sustainability Report 2024 have been published
-
Oct. 31, 2024
IR
"Investors' Meeting for FY2024 1st Half Financial Results, Management Priorities and Business Strategies" have been released.
-
Oct. 30, 2024
IR
Notice Concerning Finance Expenses (Foreign Exchange Loss) and Non-operating Expenses (Foreign Exchange Loss) in Non-consolidated Financial Statements
-
Oct. 30, 2024
IR
Sumitomo Chemical Reports Unrealized Losses on Securities as of September 30, 2024
-
Oct. 30, 2024
IR
Sumitomo Chemical Announces Revisions to Its Financial Forecast for the Full Year Ending March 31, 2025
-
Oct. 30, 2024
IR
Summary of Consolidated Financial Results for Second Quarter (Interim Period) Fiscal Year 2024
-
Sep. 18, 2024
IR
Notice Regarding the Recording of Other Operating Income in Consolidated Financial Statements and Extraordinary Income in Non-Consolidated Financial Statements due to the Transfer of a Portion of Shares Sumitomo Chemical Holds in an Associate
-
Sep. 6, 2024
IR
Notice Regarding Determination of Issuance Condition for the Third Publicly Offered Hybrid Bonds (Subordinated Bonds)
-
Aug. 8, 2024
Announcements
"Special Briefing on the Press Release regarding Petro Rabigh"has been released.
-
Aug. 7, 2024
IR
Aramco to become majority shareholder in Petro Rabigh, an integrated refining and petrochemical complex in Saudi Arabia
-
Aug. 7, 2024
IR
Notice Regarding Sale of a Portion of the Shares Sumitomo Chemical Holds in Petro Rabigh, an Associate Accounted for Using the Equity Method, and Recording of Loss on Debt Waiver for a Loan to Petro Rabigh
-
Aug. 2, 2024
IR
Notice Regarding Early Redemption of the Second Publicly Offered Hybrid Bonds (Subordinated Bonds) and Issuance of the Third Publicly Offered Hybrid Bonds (Subordinated Bonds)
-
Aug. 2, 2024
IR
Notice Concerning Share of Loss of Investments Accounted for Using the Equity Method and Finance Income (Foreign Exchange Gain)
-
Aug. 2, 2024
IR
Summary of Consolidated Financial Results for First Quarter Fiscal Year 2024
-
Jul. 19, 2024
IR
Notice Regarding Payment Completed of New Shares as Restricted Stock Compensation
-
Jul. 9, 2024
IR
Announcement of Extraordinary Loss
-
Jun. 21, 2024
IR
Notice Regarding Issuance of New Shares as Restricted Stock Compensation
-
May. 23, 2024
Announcements
Notice of the 143rd Ordinary General Meeting of Shareholders has been published.
-
May. 15, 2024
IR
Announcement of Finance Income, Restructuring Costs, and Extraordinary Loss in Non-consolidated Financial Statements
-
May. 15, 2024
IR
Summary of Consolidated Financial Results for Fiscal Year 2023
-
May. 1, 2024
Announcements
"Investors' Meeting for the Current Priority Management Issues and Business Strategy" has been released.
-
Apr. 30, 2024
IR
Investors' Meeting for the Current Priority Management Issues and Business Strategy
-
Apr. 30, 2024
IR
Sumitomo Chemical Announces Its Financial Forecast Revision for FY2023, Financial Forecast and Projected Dividend for FY2024.
-
Apr. 30, 2024
IR
Announcement of Impairment Loss
-
Mar. 13, 2024
Announcements
"Investors' Meeting for the DX Strategy" has been released.
-
Feb. 5, 2024
Announcements
"Investors' Meeting for FY2023 3rd Quarter Financial Results" has been released.
-
Feb. 2, 2024
IR
Notice Concerning Finance Expense (Foreign Exchange Loss)
-
Feb. 2, 2024
IR
Sumitomo Chemical Announces Revisions to Its Financial Forecast and Projected Dividend for the Full Year Ending March 31, 2024
-
Feb. 2, 2024
IR
Summary of Consolidated Financial Results for Third Quarter Fiscal Year 2023